Mannose binding lectin 2 haplotypes do not affect the progression of coronary atherosclerosis in men with proven coronary artery disease treated with pravastatin-Reference-Cited by-同舟云学术

Mannose binding lectin 2 haplotypes do not affect the progression of coronary atherosclerosis in men with proven coronary artery disease treated with pravastatin

Published:2011-03 Issue:1 Volume:215 Page:125-129
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Alipour Arash,Cabezas Manuel Castro,Elte Jan Willem F.,Vallvé Joan-Carles,Ribalta Josep,Zwinderman Aeilko H.,Defesche Joep C.,Jukema J. Wouter

Funder

Research Foundation Internal Medicine of the Sint Franciscus Gasthuis in Rotterdam, The Netherlands

Bristol-Myers Squibb Co, Princeton, NJ

CIBER de Diabetes y Enfermedades Metabólicas Asociadas is an ISCIII project

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference32 articles.

1. Atherosclerosis – an inflammatory disease;Ross;N Engl J Med,1999

2. Low grade inflammation and coronary heart disease: prospective study and update meta-analysis;Danesh;BMJ,2000

3. Association of mannose-binding lectin deficiency with severe atherosclerosis;Madsen;Lancet,1998

4. Prospective analysis of mannose-binding lectin genotypes and coronary artery disease in American Indians;Best;Circulation,2004

5. Infection-susceptibility alleles of mannose-binding lectin are associated with increased carotid plaque area;Hegele;J Invest Med,2000

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenomic Biomarkers in Coronary Artery Disease: A Narrative Review;Biomarkers in Medicine;2024-03

2. Association of MBL2 gene polymorphisms and MBL levels with dilated cardiomyopathy in a Chinese Han population;BMC Medical Genomics;2024-01-02

3. Mannose-binding lectin gene (MBL2) polymorphisms related to the mannose-binding lectin low levels are associated to dengue disease severity;Human Immunology;2016-07

4. The complement system and toll-like receptors as integrated players in the pathophysiology of atherosclerosis;Atherosclerosis;2015-08

5. The complement system in human cardiometabolic disease;Molecular Immunology;2014-10